Topics
July/August 2015 | Technology
A New Self-Testing System for Patients With AMD or DME
Changing treatment patterns often dictate the need for a change in disease detection.
Raj K. Maturi, MD
October 12, 2026
ANI Pharmaceuticals Reports Sustained 24-Month Efficacy of Iluvien in Phase 4 SYNCHRONICITY trial
Merck’s Remigromig Meets Primary Endpoint in Phase 2b/3 BRUNELLO Trial for DME
American Academy of Ophthalmology Announces 2026 Award Recipients at Annual Conference
Brent Saunders Departs as CEO of Bausch + Lomb
October 2026 Insert
Editorially Independent Content, Supported With Advertising From Asetllas
Editorially independent supported by Abbvie and Regenxbio
Free Print Subscription
Email Newsletter
Conference Calendar
